Trinity Biotech plc
Trinity Biotech plc (TRIB) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · TRIB · as of Sep 30, 2025
Ownership Breakdown
31
Institutional Holders
▲ 5 vs Q2
$2.81M
Total Inst. Value
▲ $1.14M vs Q2
10.39M
Shares Outstanding
freeFloat 96.43%
2.70M
13F Shares Held
▲ 143,977 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
TRIB largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
PERCEPTIVE ADVISORS LLC in vitro & in vivo diagnostic substances | 1.79M | 9.78% | 9.78% | $1.86B | Nov 14, 2025 | — held |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC in vitro & in vivo diagnostic substances | 487.1K | 2.66% | 2.66% | $502.00M | Oct 30, 2025 | ▲ 49.2K |
RENAISSANCE TECHNOLOGIES LLC in vitro & in vivo diagnostic substances | 171.4K | 93.65% | 93.65% | $178.22M | Nov 13, 2025 | ▲ 114.4K |
CITADEL ADVISORS LLC in vitro & in vivo diagnostic substances | 39.4K | 21.52% | 21.52% | $40.96M | Nov 14, 2025 | ▲ 39.4K |
CAPTRUST FINANCIAL ADVISORS in vitro & in vivo diagnostic substances | 27.2K | 14.89% | 14.89% | $28.34M | Nov 19, 2025 | NEW |
MOSS ADAMS WEALTH ADVISORS LLC in vitro & in vivo diagnostic substances | 25.7K | 14.03% | 14.03% | $26.69M | Oct 21, 2025 | — held |
TWO SIGMA INVESTMENTS, LP in vitro & in vivo diagnostic substances | 24.0K | 13.11% | 13.11% | $24.95M | Nov 14, 2025 | ▲ 8.9K |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. in vitro & in vivo diagnostic substances | 22.3K | 12.18% | 12.18% | $23.00M | Nov 12, 2025 | — held |
RAYMOND JAMES FINANCIAL INC in vitro & in vivo diagnostic substances | 20.3K | 11.10% | 11.10% | $21.13M | Nov 14, 2025 | ▼ 5.0K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP in vitro & in vivo diagnostic substances | 20.1K | 10.98% | 10.98% | $20.90M | Nov 14, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
6
Increased
+224.6K shares7
New Positions
first time holders5
Decreased
−19.2K shares5
Sold Out
fully exitedNet shares change (top 50)
+205.5K
+224.6K / −19.2K
Net new holders
+3
7 new / 5 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
TRIB insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
ROBERT R MCCORMICK TRIBUNE FOUNDATION 10 percent owner | Feb 17, 2004 | Sale | 92,000 | $52.40 | $4.82M | 38.24M | Form 4 ↗ |
ROBERT R MCCORMICK TRIBUNE FOUNDATION 10 percent owner | Feb 18, 2004 | Sale | 17,800 | $51.94 | $924.5K | 38.24M | Form 4 ↗ |
ROBERT R MCCORMICK TRIBUNE FOUNDATION 10 percent owner | Feb 13, 2004 | Sale | 65,200 | $52.04 | $3.39M | 38.24M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Trinity Biotech plc (TRIB) is primarily owned by institutional investors, who hold approximately 26.0% of total shares outstanding. Company insiders own approximately 3.57%, while retail and public investors account for the remaining 70.41%.
The largest institutional shareholder of Trinity Biotech plc is PERCEPTIVE ADVISORS LLC, holding approximately 1.79 million shares — equal to 9.78% of outstanding shares — as of September 30, 2025.
A total of 31 institutional investors currently hold TRIB stock, with a combined institutional value of approximately $2,806,724 as of the most recent 13F filing period.
Frequently asked questions
TRIB ownershipTrinity Biotech plc (TRIB) is primarily owned by institutional investors, who hold approximately 26.0% of shares. The largest shareholder is PERCEPTIVE ADVISORS LLC with a 9.78% stake. Company insiders hold 3.57%. Data sourced from SEC Form 13F as of September 30, 2025.